Cargando…
Fibrin Clot Strength in Patients with Diabetes Mellitus Measured by Thrombelastography
BACKGROUND: Patients with diabetes mellitus (DM) exhibit increased risk of recurrent myocardial infarction. Maximal clot strength measured by thrombelastography (TEG) is a risk factor for recurrent ischemic events. We hypothesized that diabetic subjects exhibit increased fibrin clot strength in plat...
Autores principales: | Maatman, Benjamin T., Schmeisser, Glen, Kreutz, Rolf P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5817329/ https://www.ncbi.nlm.nih.gov/pubmed/29507861 http://dx.doi.org/10.1155/2018/4543065 |
Ejemplares similares
-
Prediction of Ischemic Events after Percutaneous Coronary Intervention: Thrombelastography Profiles and Factor XIIIa Activity
por: Kreutz, Rolf P., et al.
Publicado: (2018) -
Assessing the Methodology for Calculating Platelet Contribution to Clot Strength (Platelet Component) in Thromboelastometry and Thrombelastography
por: Solomon, Cristina, et al.
Publicado: (2015) -
Pulmonary arterial hypertension patients display normal kinetics of
clot formation using thrombelastography
por: Lu, Mengyun, et al.
Publicado: (2021) -
Reduced clot strength upon admission, evaluated by thrombelastography (TEG), in trauma patients is independently associated with increased 30-day mortality
por: Nystrup, Kristin B, et al.
Publicado: (2011) -
Thrombelastography and sepsis
por: Puana, Rudolph, et al.
Publicado: (2007)